A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial Designed to Evaluate the Efficacy of a Telmisartan/S-Amlodipine(TelminuvoTab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

Trial Profile

A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial Designed to Evaluate the Efficacy of a Telmisartan/S-Amlodipine(TelminuvoTab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs Levamlodipine/telmisartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 25 Apr 2016 Planned End Date changed from 1 Sep 2017 to 1 Nov 2017.
    • 25 Apr 2016 Planned primary completion date changed from 1 Sep 2017 to 1 Nov 2017.
    • 04 Apr 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top